CAS: 38398-32-2; Ganaxolone

结构式图片

欧盟法规

C&L通报

上下游产品

别孕烯醇酮 Isopregnanolone 516-55-2
1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-Hydroxy-3-(Iodomethyl)-10,13-Dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydrocyclopenta[a]Phenanthren-17-Yl]Ethanone 162882-87-3
(3R)-Spiro[oxirane-2',5α-Pregnan]-20-One 148256-45-5
氢化黄体酮 Dihydroprogesterone 566-65-4
孕烯醇酮 Pregnenolone 145-13-1

合成工艺路线路线简述

  • 合成目标产物 Ganaxolone 主要起始原料 5α-Pregnane-3,20-Dione And Methylmagnesium Chloride
  • (文献来源)合成步骤主要原料 5α-Pregnane-3,20-Dione 和 Methylmagnesium Chloride
📜20,20-Ethylenedioxy-3β-Methyl-5α-Pregnan-3α-Ol置于potassium Dichromate,硫酸体系中,用 水,丙酮 作为反应溶剂,化学反应 2.0H,反应生成 加奈索酮
参考文献:Use Of Neurosteroids To Treat Neuropathic Pain
标题:Use Of Neurosteroids To Treat Neuropathic Pain
摘要:Ganaxolone(3α-羟基-3β-甲基-5β-孕酮-20-酮)和3α-羟基-3β-甲基-5β-孕酮-20-酮及其生理可分解的酯类对治疗神经病性疼痛有用.包含药用可接受的赋形剂和适当化合物的组合物以及制备该组合物的方法被披露.还披露了制造物品,其中该组合物与治疗神经病性疼痛的标签说明结合.

海关参考信息

专利信息


专利号:US-8362286-B2
优先权日:2009-08-13
标题:Method for making 3α-hydroxy, 3β- substituted-5α-pregnan-20-ones
发明人:SHAW KENNETH; HUTCHISON ALAN
权利人:MARINUS PHARMACEUTICALS INC; SHAW KENNETH; HUTCHISON ALAN
摘要:Applicants have discovered a method for the stereoselective and regioselective synthesis of 3α-hydroxy, 3β-methyl-5α-pregnan-20-one (ganaxolone) comprising reacting 5α-pregnane-3,20-dione; with an organometallic methylating agent in an inert solvent to provide a compound of the formula

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:21 CFR Sections 1308.11-1308.15
摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
摘要:Kleemann A., Kutscher B., Reichert D., Bossart M., Pharmaceutical Substances, Thieme [Online], Stuttgart, (2025).
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知